MonoFer® (Iron Isomaltoside)

MonoFer® (Iron Isomaltoside)

Monofer® is used for treating iron deficiency with and without anaemia when oral iron preparations are ineffective or cannot be used or when there is a need to deliver iron rapidly.

 

Approved in more than 36 countries globally with more than 10 million doses administered*
*based on Pharmacosmos A/S data on file, Dec 2017 (based on the WHO defined daily dose of 100mg and including doses  of iron isomoltoside under all applicable trade names)

 

 

Good safety profile

  • No dose dependency of ADRs
  • Low level of labile iron

 

Convenient

  • Meeting patient iron needs in just one visit
  • Single dose up to 20mg/kg - no other dose limits
  • No test dose required

 

Cost-effective

  • Fewer patient visits
  • Reduces waiting lists
  • Frees up treatment capacity
  • Designed for treatment of ID across multiple therapeutic areas

    • Nephrology
    • Gastroenterology
    • Obstetrics / Gynaecology
    • Surgery
    • Haematology
    • Oncology
    • Cardiology

Quicklinks >>

Compai Pharma strives to improve the lives of patients by providing access to essential products and medical devices. 

Privacy Policy   .   Terms of Use  .   Registration  & License

© 2018 Compai Pharma Pte. Ltd. All Rights Reserved.

pharmaceuticals; medical devices, pharmaceutical distribution, in-licensing, registration, disease awareness, pharma sales and marketing, asia, Singapore, Malaysia,